Vimarsana
Biggest News Aggregation in the World

Page 5 - Poster Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Number Today - Breaking & Trending Today

Berkshire Biomedical Announces Two Poster Presentations at the CPDD 85th Annual Scientific Meeting - Vimarsana News

Berkshire Biomedical Announces Two Poster Presentations at the CPDD 85th Annual Scientific Meeting

/PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance...

Nanoscope Therapeutics Announces Presentations at the 2023 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting - Vimarsana News

Nanoscope Therapeutics Announces Presentations at the 2023 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting

/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today...

EQS-News: Immunic, Inc.: Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action - Vimarsana News

EQS-News: Immunic, Inc.: Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

Issuer: Immunic, Inc. / Key word(s): Study/Conference Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action 06.05.2023

Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action - Vimarsana News

Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

EQS-News: Immunic to Participate in Investor and Scientific Conferences in May - Vimarsana News

EQS-News: Immunic to Participate in Investor and Scientific Conferences in May

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in May 26.04.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences in May NEW YORK, A...